
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $2.2M | -- | -- | -$0.07 | -- |
08/08/2025 | Q2 | $2M | -- | -- | -$0.10 | -- |
05/13/2025 | Q1 | -- | $20.9M | -$0.07 | -$0.07 | -- |
03/20/2025 | Q4 | $20.8M | $15.2M | -$0.05 | -$0.11 | $0.06 |
11/13/2024 | Q3 | $1.9M | $4.9M | -$0.06 | -$0.09 | $0.03 |
08/08/2024 | Q2 | $22M | $6.4M | -$0.09 | $0.04 | -$0.13 |
05/13/2024 | Q1 | $800K | $2.2M | -$0.14 | -$0.18 | $0.04 |
03/14/2024 | Q4 | $1.1M | $6.6M | -$0.12 | -$0.14 | $0.02 |
11/02/2023 | Q3 | -- | -- | -$0.11 | -$0.18 | $0.07 |
08/03/2023 | Q2 | -- | -- | -$0.16 | -$0.17 | $0.01 |
05/04/2023 | Q1 | -- | -- | -$0.19 | -$0.16 | -$0.03 |
03/15/2023 | Q4 | -- | -- | -$0.18 | -$0.23 | $0.05 |
11/08/2022 | Q3 | -- | -- | -$0.23 | -$0.25 | $0.02 |
08/08/2022 | Q2 | -- | -- | -$0.23 | -$0.21 | -$0.02 |
05/09/2022 | Q1 | -- | -- | -$0.20 | -$0.17 | -$0.03 |
02/24/2022 | Q4 | -- | -- | -$0.17 | -$0.16 | -$0.01 |
11/04/2021 | Q3 | -- | -- | -$0.14 | -$0.14 | -- |
08/05/2021 | Q2 | -- | -- | -$0.13 | -$0.14 | $0.01 |
05/06/2021 | Q1 | -- | -- | -$0.14 | -$0.10 | -$0.04 |
02/25/2021 | Q4 | -- | -- | -$0.13 | -$0.06 | -$0.08 |
11/12/2020 | Q3 | -- | -- | -$0.08 | -$0.09 | $0.01 |
08/06/2020 | Q2 | -- | -- | -$0.12 | -$0.06 | -$0.07 |
05/12/2020 | Q1 | -- | -- | -$0.02 | -$0.04 | $0.02 |
03/19/2020 | Q4 | -- | -- | -$0.13 | -$0.13 | -- |
09/30/2019 | Q3 | -- | -- | -$0.32 | -- | -- |
08/09/2019 | Q2 | -- | -- | -$0.39 | -- | -- |
03/31/2019 | Q1 | -- | -- | -$0.18 | -- | -- |
12/31/2018 | Q4 | -- | -- | -$0.69 | -- | -- |
09/30/2018 | Q3 | -- | -- | -$0.92 | -- | -- |
08/09/2018 | Q2 | -- | -- | -$1.24 | -- | -- |
05/15/2018 | Q1 | -- | -- | $0.49 | -- | -- |
12/31/2017 | Q4 | -- | -- | -$0.99 | -- | -- |
09/30/2017 | Q3 | -- | -- | -$1.54 | -- | -- |
08/31/2017 | Q2 | -- | -- | -$1.65 | -- | -- |
05/04/2017 | Q1 | -- | -- | -$1.21 | -- | -- |
02/02/2017 | Q4 | -- | -- | -$2.64 | -- | -- |
11/03/2016 | Q3 | -- | -- | -$2.86 | -- | -- |
09/08/2016 | Q2 | -- | -- | -$1.98 | -- | -- |
05/05/2016 | Q1 | -- | -- | -$1.54 | -- | -- |
01/29/2016 | Q4 | -- | -- | -$1.87 | -- | -- |
11/06/2015 | Q3 | -- | -- | -$1.87 | -- | -- |
Vaxart reported $20.9M worth of top line sales in its most recent quarter.
Vaxart announced earnings per share of -$0.07 which represents a miss of analyst forecast a -$0.07 per share.
Vaxart reported -- that represents -- per share over the last quarter.
Vaxart's earnings are forecast to decrease from -$0.33 per share to -$0.40 per share next year representing a decrease of -12.12%.
Vaxart's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.